Sudeep Pharma P/E Ratio
Sudeep Pharma (SUDEEPPHRM) P/E ratio is 54.93 (High), EPS (TTM) ₹15.50, current price ₹868.05 on NSE vs historical average P/E of 50.27 (100.0th percentile) — Very High - High growth expectations or significantly overvalued. For live price, revenue and the complete fundamental profile, see Sudeep Pharma share price chart.
Current Valuation Metrics
Valuation Signal
Sector Context
Earnings Breakdown (TTM)
SUDEEPPHRM P/E Ratio — Valuation Signal & Historical Context
Sudeep Pharma P/E 54.93 vs historical average 50.27, range 50.27–50.27 — signal: Overvalued. Read Sudeep Pharma dividend payments for the complete payout history and dividend yield track record.
- Stock appears overvalued with PE of 54.93, suggesting caution for new investments
Sudeep Pharma P/E Ratio Historical Trend
SUDEEPPHRM annual price-to-earnings ratio — 1 years, EPS and year-end price. Current P/E 54.93 vs historical average 50.27. See SUDEEPPHRM price to book ratio to compare market price against book value per share.
SUDEEPPHRM Historical P/E Ratio — EPS, Year-End Price & Valuation
Sudeep Pharma annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.
| Year | P/E Ratio | EPS (₹) | Year-end Price (₹) | Exchange | Valuation |
|---|---|---|---|---|---|
| 2025 | 50.27 | 15.4 | ₹774.15 | NSE | High |
SUDEEPPHRM vs Healthcare Peers — P/E Ratio Comparison
Sudeep Pharma P/E 54.93 vs Healthcare average 54.8, median 31.04 — range 2.86–950.0.
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Sunrest Lifescience | SUNREST | 3.65 | ₹29 | Low |
| Phaarmasia | PHRMASI | 3.89 | ₹69 | Low |
| JFL Life Sciences | JFLLIFE | 4.64 | ₹59 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.69 | ₹7,502 | Low |
| Shelter Pharma | SHELTER | 5.32 | ₹50 | Low |
| Mono Pharmacare | MONOPHARMA | 6.02 | ₹19 | Low |
| Royal Sense | ROYAL | 7.4 | ₹51 | Low |
| Zenith Drugs | ZENITHDRUG | 7.69 | ₹79 | Low |
| Amwill Health Care | AMWILL | 7.71 | ₹88 | Low |